SCHEMBL21623385

SCHEMBL21623385

c1ccc(-c2nc3ccccc3nc2-n2c3ccccc3c3c2ccc2nc4ccccc4n23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.43
POLB P06746 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 5/20 0.40
HPGD P15428 3/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 1/20 0.40
RXFP1 Q9HBX9 2/20 0.40
CASP1 P29466 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
ADORA2A P29274 2/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
PDE10A Q9Y233 2/20 0.35
DHODH Q02127 1/20 0.35
CFTR P13569 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21364442 0.83 ALDH1A1 (0.47) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL24036838 0.81 HSD17B10 (0.50) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL21364430 0.80 KDM4E (0.49) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL23917085 0.80 KDM4E (0.42) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL19655101 0.79 HSD17B10 (0.46) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL24104201 0.79 HSD17B10 (0.48) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL20152135 0.77 HSD17B10 (0.43) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL19655119 0.76 HSD17B10 (0.46) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL19655137 0.76 HSD17B10 (0.46) HSD17B10POLBMEN1KMT2AKDM4E
SCHEMBL22722294 0.76 HSD17B10 (0.41) HSD17B10POLBMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11581497-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-02-14 US disclosed
EP-3820966-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-06-08 EP disclosed
US-20210320264-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-14 US disclosed
WO-2020011686-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11581497-B2 Materials for organic electroluminescent devices OR10J3, EPCAM, L1CAM HSD17B10 3308/4885POLB 2198/4885MEN1 1639/4885
US-20210320264-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES OR10J3, EPCAM, L1CAM HSD17B10 3308/4885POLB 2198/4885MEN1 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.